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Aims: To establish a clinical, histopathological, and
genetic diagnosis in two unrelated British families with
Avellino corneal dystrophy (ACD).
Methods: Genomic DNA was extracted from peripheral
blood leucocytes of all members participating in the study.
Exons 4 and 12 of the human transforming growth factor β
induced (BIGH3) gene were amplified by polymerase
chain reaction. The mutation and polymorphism were
identified by direct sequencing and restriction digest
analysis. A review of the patients’ clinical symptoms and
signs was undertaken and a histopathological study on
corneal specimen obtained from the proband of one fam-
ily after keratoplasty was performed.
Results: A heterozygous G to A transition at the second
nucleotide position of codon 124 of BIGH3 gene was
detected in all affected members of both families. This
mutation changes an arginine residue to a histidine. The
clinical diagnosis for ACD was more evident with advanc-
ing age. Histopathological study revealed granular depos-
its in the anterior stroma and occasional positive Congo
red areas of amyloid deposition in the mid to deep stroma
typical of ACD.
Conclusions: This is the first report of ACD families in the
United Kingdom and, furthermore, of BIGH3 gene
mutation in British patients with this rare type of corneal
dystrophy. The results indicate that BIGH3 gene screening
along with clinical and histopathological examinations is
essential for the diagnosis and clinical management of cor-
neal dystrophies.
Avellino corneal dystrophy (ACD; OMIM 121900) is a vari-ant of granular corneal dystrophy Groenouw type 1(CDGG1; OMIM 12100) in which both Groenouw-like
and lattice-like changes co-exist in the same cornea.1 The con-
dition has been named Avellino, after the Italian province near
Naples where the first affected families originated.1 However,
the condition has also been reported in Germany,2 Ireland,3
Europe,4 Japan,5–8 and France.9
The earliest clinical evidence of ACD is the development of
small, discrete and sharply demarcated granular deposits in
the subepithelial and anterior stromal layers of the cornea. As
the condition progresses the deposits increase in size and
number, and lattice lesions develop in the mid to posterior
corneal stroma.10 These lattice lesions are larger, denser,
whiter, and more spiculated than those of lattice corneal dys-
trophy type I (CDLI; OMIM 122000).11 Stromal haze is the last
clinical sign to emerge; thus, all patients with stromal haze
had both granular and lattice lesions, representing the most
advanced form of the disease.10
Histologically, granular deposits that stained with Masson’s
trichrome and Congo red positive fusiform deposits of amyloid
are found in the corneal stroma.2 12–14
ACD, CDGGI, CDLI, and Reis-Bücklers corneal dystrophy
(RBCD; OMIM 121900), have been found to be due to differ-
ent missense mutations within a human transforming growth
factor β induced (BIGH3; OMIM 601692) gene on chromo-
some 5q31.4 ACD has been reported to be caused by
heterozygous R124H mutation in the BIGH3 gene.4
Here, two unrelated British families have been studied
clinically, histopathologically and genetically. Our results
revealed a heterozygous G to A transition at the second nucle-
otide position of codon 124 in the BIGH3 gene in all affected
members of both families. Clinically the diagnosis of ACD was
more evident in the older individuals rather than younger
cases and the histopathological diagnosis of one case who
underwent keratoplasty was typical for ACD. These results
further highlight on the importance of BIGH3 gene screening
to establish a precise diagnosis of corneal dystrophies.
METHODS
Case reports
The study had the approval of Moorfields Eye Hospital local
research ethics committee and conformed to the tenets of the
Declaration of Helsinki. Informed consent from all partici-
pants was obtained for clinical and molecular genetic study.
The pedigrees are shown in Figure 1.
Family A
Case II-1 (the proband) was first examined at the cornea and
external disease clinic in 1990 at the age of 72 years, when she
Figure 1 Pedigrees of the families participating in the study. Open
and closed symbols indicate unaffected and affected individuals,
respectively, arrows indicate the proband in each family, and
asterisks indicate individuals examined.
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complained of visual disturbance. The patient’s best corrected
visual acuity at the initial examination was 6/60 in the right eye
and 6/18 in the left eye. Slit lamp biomicroscopic examination
showed discrete dot opacities with interspersed thick lattice
lines in between and the condition was diagnosed as an atypi-
cal form of granular corneal dystrophy (Fig 2). The patient also
had cataract but no other ocular abnormalities were present.
Extracapsular cataract extraction and intracapsular lens
implantation were performed in the right eye in 1990, where
right eye visual acuity was improved to 6/36 unaided. Penetrat-
ing keratoplasty in the right eye was then performed in 1991
which further improved her visual acuity to 6/18 unaided.
Histopathological examination of her corneal specimen
showed an amorphous eosinophilic deposit in the anterior
stroma, which stained positively with Masson’s trichrome
stain and occasional areas of amyloid deposition in the deep
stroma, which stained positively with Congo red stain (Fig 3).
These criteria were typical of ACD.
Case III-3 (the proband’s son) was referred to the same clinic in
1996 at the age of 38 years, when he complained of bilateral
decrease in visual acuity. He had been diagnosed as having a
corneal dystrophy when he attended the casualty department
for removal of a foreign body in 1980. The patient’s unaided
visual acuity was 6/9 in either eye improving to 6/6 with pin-
hole. Slit lamp examination revealed discrete granular depos-
its in the anterior stromal layer and star-like deposits which
are typical of ACD. In 1994 the patient’s visual acuity deterio-
rated and right excimer laser phototherapeutic keratectomy
had been performed, which improved his vision.
Case III-1 (the proband’s daughter) was a 25 year old and the
slit lamp examination of her cornea revealed large number of
central granules, but no lattice changes were observed. The
patient’s unaided visual acuity was 6/9 in both eyes and she
required no intervention.
Case II-5 (the proband’s sister) was completely free of corneal
intervention as determined by slit lamp biomicroscopic exam-
ination of her corneas.
Family B
The second family consisted of 90 year old proband (case I-1)
and 63 year old son (case II-1). Slit lamp examination of their
corneas showed a typical picture of ACD. They had no history
of keratoplasty. Examination of the proband’s daughter (case
II-2) revealed that she was completely free of corneal disease.
All members of both families were born in England and
both families’ origin has been traced to the United Kingdom.
Figure 2 Slit lamp photographs of ACD in the upper (A) and lower
(B) corneas of the proband from family A showing fusiform,
branching, and white breadcrumb deposits.
Figure 3 Light microscopic study of corneal specimen from the
proband of family A. (A) Subepithelial fusiform and anterior stromal
deposits stained pink with Congo red (×10). (B) Focal accumulation
of hyaline stained bright red with Massone’s trichrome; subepithelial
hyaline material and connective tissue (×20). (C) Characteristic
birefringence seen with polarised light in amyloid deposits (×20).
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They have no relatives of Italian origin, making them the first
British families to be reported with ACD.
Mutation detection
Genomic DNA was extracted from 10 ml blood samples
obtained from all subjects involved in the study according to
the standard protocol. Exons 4 and 12 of BIGH3 gene were
amplified by polymerase chain reaction (PCR) using the
following primer pairs (exon 4, 5’-tccctccttctgtcttctgc -3’/5’-
agactcccattcatcatgcc-3’; exon 12, 5’-tcaatccttgatgtgccaac-3’/5’-
aaaatacctctcagcgtggtg-3’). Each PCR reaction was carried out
in a 50 µl reaction mixture containing genomic DNA (200 ng),
primers (0.4 µM each), MgCl2 (1.5 mM), dNTPs (0.2 mM), 1X
PCR buffer (containing 10 mM TRIS-HCl, pH 8.3, 50 mM KCl,
and 0.1% gelatin), and Taq polymerase (0.5 U; Bioline). Ampli-
fication reactions were performed using the following
conditions (3 minutes of denaturation at 94°C followed by 35
cycles of denaturation at 94°C for 1 minute, annealing at 62°C
for 1 minute, extension at 72°C for 1 minute, and further
extension step at 72°C for 5 minutes).
For direct sequencing, PCR products were purified using the
Qiaquik PCR purification kit (Qiagen) and sequenced using an
automatic fluorescent DNA sequencer (ABI Prism 373A,
Perkin Elmer, Foster City, CA, USA) following manufacturers
instructions. Nucleotide sequences for the coding regions were
compared with the nucleotide sequence of the published
BIGH3 human cDNA.15
Co-segregation study on the family members was per-
formed using restriction enzyme digest analysis to confirm
the mutation detected by sequencing. Exon 4 primer pairs
were used to PCR amplify a 310 bp product as described above,
which was subsequently digested overnight at 30°C with 1
unit of CSPI enzyme (Promega) and analysed on 3% agarose
gel. The recognition sequence for the enzyme is 5 . . .[/
]CGG[_](A/T)CCG[/ . . .]3, which is abolished by the mutation.
RESULTS
Direct sequencing analysis of BIGH3 exon 4 in the probands
from both families participating in this study revealed a single
heterozygous base pair transition at nucleotide position 418
(G to A), which converts an arginine at codon 124 into a his-
tidine shown in Figure 4. This mutation has previously been
identified in ACD.4
The unaffected members of both families did not have the
mutation as determined by a cosegregation study using
restriction analysis in which the mutation abolishes the
recognition site of CSPI. The three affected members from
family A and the two affected from family B showed one
undigested product of the expected size (310 bp) for the
mutant allele plus two restriction digest products (190 bp and
110 bp) from the normal allele. Unaffected members from
both families revealed two restriction digest fragments (190
bp and 110 bp) as shown in Figure 5.
BIGH3 exon 12 sequencing revealed a polymorphism with T
to C transition at nucleotide position 1620 in the proband from
family B. This polymorphism does not change the amino acid
sequence of the encoded protein, and it has also been reported
previously.16 17
DISCUSSION
ACD is an autosomal dominant disorder that usually appears
in the first or second decade of life.1 It consists of granular and
lattice changes in the same eye and results from a specific
mutation in the BIGH3 gene on chromosome 5q31.4
The majority of ACD families were found to trace their ances-
try to the large region of Campania in Italy which contains
cities of Naples, Avellino, Lioni, and Stio. However, many cases
of ACD have been reported in patients of different origins,
including German, Japanese, Irish, Swiss, and French.2–6 8 9
In this study we describe for the first time two pedigrees of
ACD in the United Kingdom indicating that the condition may
occur in any population.
The younger individual (case III-1 in family A) demon-
strated predominantly granular stromal opacities and the
appearance of lattice changes occurred gradually, starting later
Figure 4 Electropherograms of the BIGH3 gene. (A) The proband
of family A showing a heterozygous G to A transition at codon 124,
(CGC→CAC, R124H). (B) The proband’s daughter from family A
depicting normal sequence.
Figure 5 Co-segregation study
with CSPI restriction enzyme.
Lane 1 is undigested PCR product
(310 bp). The two affected
individuals (lanes 2 and 3) from
family B showing one undigested
product of the expected size
(310 bp) for the mutant allele
plus two restriction digest
products (190 and 110 bp) from
the normal allele. Unaffected
member (lane 4) showing two
restriction digest fragments (190
and 110 bp). M is the φX174 RF
DNA Hae III marker.
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in life, and increasing with age. Thus, the dystrophic process
progresses with age. This observation supports and extends
those of previous reports.1 2 6 10 18
Molecular genetic analysis showed that all five patients in
both families participating in this study, had heterozygous
R124H BIGH3 gene mutation which is identical to the
mutation reported previously for ACD.4 It appears that the
unique phenotype of ACD is caused by this particular amino
acid change. This fact is supported by the finding that differ-
ent amino acid changes in the same position result in different
phenotypes R124C results in LCDI,4 R124L results in the geo-
graphic form of RBCD,19 and R124S results in atypical form of
CDGG1,20 and even the homozygous form of the same change
(R124H) results in a severe variant of CDGG1 which is charac-
terised by juvenile onset and confluent superficial discrete
opacity.21 Thus the heterozygous R124H mutation of the
BIGH3 gene is particularly linked to ACD phenotype. However,
Stewart et al20 reported that the heterozygous R124H mutation
of the BIGH3 gene resulted in an atypical form of CDGGI
which was confirmed histopathologically by absence of amy-
loid deposits. Thus, genetic and histopathological evaluation
are both essential for correct diagnosis of these dystrophies
In conclusion, this is the first reported BIGH3 gene
mutation in ACD families from the United Kingdom. Our
results confirm the importance of BIGH3 gene screening as a
mandatory step for the diagnosis of ACD, particularly in the
younger age group. This information will be useful for future
genetic counselling, as well as gene therapy.
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